[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@BioTechTraderSD Avatar @BioTechTraderSD Truth Hunter

Truth Hunter posts on X about $rlyb, breakout, $140share, balance sheet the most. They currently have XXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.

Engagements: XXXXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence stocks finance

Social topic influence $rlyb #1, breakout #1144, $140share #1, balance sheet, $jspr, $adct, $clnn, $bdtx, sleeper, future

Top accounts mentioned or mentioned by @biovalues @6kinvestor @collectinghurts @monacobiotech @phxcollins @dmitrykovalchuk @ltbioinvestor @dogtor01416800 @ernieworthingk9 @oncinvestor @kevin46101663 @aaronrosenblum5 @potus @realdonaldtrump @elmonogran42994 @giger1964 @jeromeleonard5 @biopharmiq @michel @biopharmacaster

Top assets mentioned ADC Therapeutics SA (ADCT) Amgen, Inc. (AMGN) Biogen Inc (BIIB)

Top Social Posts

Top posts by engagements in the last XX hours

"Oh boy every chatroom gonna be chasing $RLYB soon"
X Link 2025-12-10T16:21Z XXX followers, XXX engagements

"With $1.40/share cash on balance sheet $RLYB has good chance to XXX% + on this month's C5 readout. If program validated they will be moving into two phase X trials in 2026"
X Link 2025-12-11T17:03Z XXX followers, XXX engagements

"$JSPR $ADCT $CLNN $BDTX all down on data. Biotech top may finally be in"
X Link 2025-12-03T16:17Z XXX followers, XXX engagements

"$RLYB non stop uptrend. Buyout on C5 data IMO"
X Link 2025-12-10T14:50Z XXX followers, XXX engagements

"Sleeper $RLYB one of last December data plays with minimal risk. Trades XX% below cash with potentially best in class C5 inhibitor. Two phase X programs to potentially start 2026. Very mispriced here ahead of topline PK/PD data"
X Link 2025-12-03T16:25Z XXX followers, XXX engagements

"$rlyb breakout coming ahead of December data which will determine future of the company. $1.40/share in cash"
X Link 2025-12-09T14:59Z XXX followers, XXX engagements

"Continue to add to $rlyb ahead of topline cohort 1+2 c5 inhibition data. XX% below cash with two c5a inhibitors in pipeline. Two trials to begin 2026. Think we see major pop on heels of $ifrx $amgn"
X Link 2025-11-11T15:46Z XXX followers, XXX engagements

"$RLYB nearing major breakout area. Topline C5 knockdown + safety from Cohort X + X in the next few weeks. XX% below cash in a very hot space"
X Link 2025-11-11T18:59Z XXX followers, XXX engagements

"Would not be surprised to see $RLYB get bought out in tandem with their C5 data this month. Given they are essentially a shell have laid off XX% of their staff and the $BIIB C5 deal in October it makes sense to give their legacy VCs an exit (many with averages $10)"
X Link 2025-12-09T16:29Z XXX followers, XXX engagements

"$RLYB unstoppable. Breakout"
X Link 2025-12-10T14:49Z XXX followers, XXX engagements

"$RLYB - Whatever is coming this month is going to be a banger for shareholders. Explains why no funds are selling"
X Link 2025-12-11T18:29Z XXX followers, XXX engagements

"$RLYB has FIVE very underwater VCs. They want an exit and I have seen deals done with them before in situations like this. Whatever is coming will create significant value"
X Link 2025-12-11T19:09Z XXX followers, XXX engagements

"$RLYB - interesting theory. CEO of $RLYB is former head of research at Alexion (now part of AstraZeneca). Alexion specialized in C5 inhibitors and has one recently approved (ravulizumab). 1/2"
X Link 2025-12-11T22:55Z XXX followers, XXX engagements

"So AstraZeneca has two FDA approved C5 inhibitors thanks to Alexion and is investing in multiple more programs. Makes sense that they absorb $RLYB given their huge investment in C5 programs and infrastructure. We will see"
X Link 2025-12-11T22:55Z XXX followers, XXX engagements